0000899140-23-001108.txt : 20231114
0000899140-23-001108.hdr.sgml : 20231114
20231114163020
ACCESSION NUMBER: 0000899140-23-001108
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20230930
FILED AS OF DATE: 20231114
DATE AS OF CHANGE: 20231114
EFFECTIVENESS DATE: 20231114
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sarissa Capital Management LP
CENTRAL INDEX KEY: 0001577524
IRS NUMBER: 900924432
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-15935
FILM NUMBER: 231406941
BUSINESS ADDRESS:
STREET 1: 660 STEAMBOAT ROAD
CITY: GREENWICH
STATE: CT
ZIP: 06830
BUSINESS PHONE: 203-302-2330
MAIL ADDRESS:
STREET 1: 660 STEAMBOAT ROAD
CITY: GREENWICH
STATE: CT
ZIP: 06830
13F-HR
1
primary_doc.xml
X0202
13F-HR
LIVE
0001577524
XXXXXXXX
09-30-2023
09-30-2023
false
Sarissa Capital Management LP
660 STEAMBOAT ROAD
GREENWICH
CT
06830
13F HOLDINGS REPORT
028-15935
N
Alexander J. Denner, Ph.D.
Chief Investment Officer
203-302-2330
/s/ Alexander J. Denner
Greenwich
CT
11-14-2023
0
11
742379576
INFORMATION TABLE
2
informationtable.xml
ALKERMES PLC
SHS
G01767105
197252022
7042200
SH
SOLE
7042200
0
0
AMARIN CORP PLC
SPONS ADR NEW
023111206
9607057
10442453
SH
SOLE
10442453
0
0
BIOCRYST PHARMACEUTICALS INC
COM
09058V103
5487000
775000
SH
SOLE
775000
0
0
BIOGEN INC
COM
09062X103
165257430
643000
SH
SOLE
643000
0
0
GILEAD SCIENCES INC
COM
375558103
68974776
920400
SH
SOLE
920400
0
0
INNOVIVA INC
COM
45781M101
94528230
7277000
SH
SOLE
7277000
0
0
IRONWOOD PHARMACEUTICALS INC
COM CL A
46333X108
157835700
16390000
SH
SOLE
16390000
0
0
MERSANA THERAPEUTICS INC
COM
59045L106
698500
550000
SH
SOLE
550000
0
0
NEUROCRINE BIOSCIENCES INC
COM
64125C109
41175000
366000
SH
SOLE
366000
0
0
REGULUS THERAPEUTICS INC
COM
75915K309
253701
185183
SH
SOLE
185183
0
0
VOR BIOPHARMA INC
COM
929033108
1310160
618000
SH
SOLE
618000
0
0